Rationale and proposed algorithms for symptom-based proton pump inhibitor therapy for gastro-oesophageal reflux disease
Authors:
- 21 July 2004
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 20 (4) , 389-398
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Six‐month trial of on‐demand rabeprazole 10 mg maintains symptom relief in patients with non‐erosive reflux diseaseAlimentary Pharmacology & Therapeutics, 2004
- Self-selection and use patterns of over-the-counter omeprazole for frequent heartburnClinical Gastroenterology and Hepatology, 2004
- Dyspepsia after withdrawal of omperazole in healthy volunteersGastroenterology, 2003
- On-demand therapy with pantoprazole 20 mg as effective long-term managemnt of patients suffering from mild GERDGastroenterology, 2003
- Does Short-term Treatment With Proton Pump Inhibitors Cause Rebound Aggravation of Symptoms?Journal of Clinical Gastroenterology, 2001
- On demand therapy with omeprazole for the long‐term management of patients with heartburn without oesophagitis—a placebo‐controlled randomized trialAlimentary Pharmacology & Therapeutics, 1999
- An evidence-based appraisal of reflux disease management — the Genval Workshop ReportGut, 1998
- Atrophic Gastritis andHelicobacter pyloriInfection in Patients with Reflux Esophagitis Treated with Omeprazole or FundoplicationNew England Journal of Medicine, 1996
- SELF-DIRECTED TREATMENT OF INTERMITTENT HEARTBURNAmerican Journal of Therapeutics, 1995
- Symptoms in gastro-oesophageal reflux diseaseThe Lancet, 1990